Sadowski Daniel C, Kolber Michael R, Gomes Anthony, Hickle Linda, Hilsden Robert, McLean David Ross, Mok Dereck, Moysey Barbara, Nemecek Nicole, Ryan John David, Sultanian Richard, Wiseman Jessica, Yang Huiming
Division of Gastroenterology, University of Alberta, Edmonton, Canada, T6G 2X8.
Department of Family Medicine, University of Alberta, Canada, T6G 2T4.
J Can Assoc Gastroenterol. 2024 Mar 19;7(4):319-328. doi: 10.1093/jcag/gwae007. eCollection 2024 Aug.
In 2013, the Alberta Colorectal Cancer Screening Program (ACRCSP) initially published recommendations for post-colonoscopy follow-up and polypectomy. Over time, emerging evidence and evolving surveillance guidelines from various expert groups necessitated a comprehensive review to align with the healthcare landscape in Alberta. To accomplish this, an expert panel was convened. Using the Agree II tool, we identified high-quality Clinical Practice Guidelines that were relevant to the Alberta medical context. Recommendations from these guidelines were adapted to fit the specific needs of Alberta. Recognizing inconsistencies and gaps within the existing guidelines, we conducted targeted literature reviews to ensure a comprehensive and evidence-based approach to our recommendations. Our revised recommendations build upon the assumption that a high-quality index colonoscopy has been performed at baseline. They are intended to enhance the quality of care and reduce unnecessary procedures. As well, they align with the growing consensus in the scientific literature that individuals with low-risk tubular adenomas may not require aggressive colonoscopy surveillance. The updated Alberta recommendations aim to provide clear recommendations for practicing endoscopists, referring physicians, and their patients. They address crucial questions such as determining which patients should commence surveillance via colonoscopy and which individuals should return to average-risk screening using the fecal immunochemical test (FIT). Additionally, our recommendations outline the appropriate surveillance intervals for those requiring continued monitoring.
2013年,艾伯塔省结直肠癌筛查项目(ACRCSP)首次发布了结肠镜检查后随访及息肉切除的建议。随着时间的推移,来自各个专家小组的新证据和不断演变的监测指南使得有必要进行全面审查,以与艾伯塔省的医疗环境保持一致。为实现这一目标,召集了一个专家小组。我们使用《AGREE II工具》,确定了与艾伯塔省医疗背景相关的高质量临床实践指南。这些指南中的建议经过调整,以适应艾伯塔省的具体需求。认识到现有指南中存在的不一致和差距,我们进行了有针对性的文献综述,以确保我们的建议采用全面且基于证据的方法。我们修订后的建议基于在基线时已进行高质量结肠镜检查的假设。它们旨在提高护理质量并减少不必要的程序。此外,它们与科学文献中越来越多的共识一致,即低风险管状腺瘤患者可能不需要积极的结肠镜监测。更新后的艾伯塔省建议旨在为执业内镜医师、转诊医生及其患者提供明确的建议。它们解决了一些关键问题,例如确定哪些患者应通过结肠镜检查开始监测,以及哪些个体应恢复使用粪便免疫化学检测(FIT)进行平均风险筛查。此外,我们的建议还概述了那些需要持续监测的患者的适当监测间隔。